Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

多黏菌素类合理应用国际共识指南

2019-07-20 中国感染与化疗杂志.2019,19(4):460-463.

多粘菌素最佳应用

多黏菌素类抗生素是目前临床用于治疗难治性革兰阴性菌感染的重要药物，在国内临床应用也呈增多趋势，但对该类药物的认识尚有不足。日前美国临床药学院（ACCP）、欧洲临床微生物和感染病学会（ESCMID）、美国感染病学会（IDSA）、国际抗感染药学会（ISAP）、重症医学会（SCCM）和感染病药师学会（SIDP）等6家国际权威学会联合发布多黏菌素类合理应用共识指南其中基于近年来新的循证依据，对品种和剂型的

中文标题：

多黏菌素类合理应用国际共识指南

发布机构：

发布日期：

2019-07-20

简要介绍：

多黏菌素类抗生素是目前临床用于治疗难治性革兰阴性菌感染的重要药物，在国内临床应用也呈增多趋势，但对该类药物的认识尚有不足。日前美国临床药学院（ACCP）、欧洲临床微生物和感染病学会（ESCMID）、美国感染病学会（IDSA）、国际抗感染药学会（ISAP）、重症医学会（SCCM）和感染病药师学会（SIDP）等6家国际权威学会联合发布多黏菌素类合理应用共识指南其中基于近年来新的循证依据，对品种和剂型的选择、给药剂量及其调整、药动学/药效学治疗靶值等作了推荐。现将其中要点作成编译，以供读者参考。

译者： 复旦大学附属华山医院抗生素研究所 陈轶坚

 

拓展指南：与多粘菌素相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=多黏菌素类合理应用国际共识指南)] GetToolGuiderByIdResponse(projectId=1, id=be4de1c001e82106, title=多黏菌素类合理应用国际共识指南, enTitle=, guiderFrom=中国感染与化疗杂志.2019,19(4):460-463., authorId=null, author=, summary=多黏菌素类抗生素是目前临床用于治疗难治性革兰阴性菌感染的重要药物，在国内临床应用也呈增多趋势，但对该类药物的认识尚有不足。日前美国临床药学院（ACCP）、欧洲临床微生物和感染病学会（ESCMID）、美国感染病学会（IDSA）、国际抗感染药学会（ISAP）、重症医学会（SCCM）和感染病药师学会（SIDP）等6家国际权威学会联合发布多黏菌素类合理应用共识指南其中基于近年来新的循证依据，对品种和剂型的, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Jul 20 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>多黏菌素类抗生素是目前临床用于治疗难治性革兰阴性菌感染的重要药物，在国内临床应用也呈增多趋势，但对该类药物的认识尚有不足。日前美国临床药学院（ACCP）、欧洲临床微生物和感染病学会（ESCMID）、美国感染病学会（IDSA）、国际抗感染药学会（ISAP）、重症医学会（SCCM）和感染病药师学会（SIDP）等6家国际权威学会联合发布多黏菌素类合理应用共识指南其中基于近年来新的循证依据，对品种和剂型的选择、给药剂量及其调整、药动学/药效学治疗靶值等作了推荐。现将其中要点作成编译，以供读者参考。</P>译者： 复旦大学附属华山医院抗生素研究所 陈轶坚 <P> </P>拓展指南：<strong>与<font color=red>多粘菌素</font>相关指南：</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=3537c1c001e01232" title="2019 国际共识指南：多粘菌素的最佳应用" target=_blank>2019 国际共识指南：多粘菌素的最佳应用</a></li> 更多信息请点击：<a href="//m.capotfarm.com/guideline/list.do?q=%E5%A4%9A%E7%B2%98%E8%8F%8C%E7%B4%A0" target=_blank>有关多粘菌素更多指南</a></ul>, tagList=[TagDto(tagId=86520, tagName=多粘菌素), TagDto(tagId=86521, tagName=最佳应用)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11472, appHits=321, showAppHits=0, pcHits=9477, showPcHits=2861, likes=52, shares=21, comments=7, approvalStatus=1, publishedTime=Tue Aug 20 22:13:19 CST 2019, publishedTimeString=2019-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 20 22:13:19 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 05:47:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=多黏菌素类合理应用国际共识指南)])
多黏菌素类合理应用国际共识指南
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=953235, encodeId=c4979532355b, content=恭喜贺喜高跟鞋, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:52 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953234, encodeId=00fc95323404, content=jxkmamk, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:13 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951743, encodeId=06b9951e4345, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37e5423044, createdName=ms6000000252401279, createdTime=Sun Mar 28 08:18:24 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895979, encodeId=c3338959e90e, content=多谢多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/4e67da775f024966bfa59cc158cc8c46/c54a72ef28e94653944444c8f52cc1f2.jpg, createdBy=3eb15410031, createdName=ms6000001661297382, createdTime=Sun Nov 01 00:33:46 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373199, encodeId=b80f3e3199f1, content=多谢分享，让我们了解最新的医药资讯！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c15176498, createdName=146e9b3fm43暂无昵称, createdTime=Wed Sep 25 23:41:48 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-04-02 ms5000000127232937

    恭喜贺喜高跟鞋

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=953235, encodeId=c4979532355b, content=恭喜贺喜高跟鞋, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:52 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953234, encodeId=00fc95323404, content=jxkmamk, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:13 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951743, encodeId=06b9951e4345, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37e5423044, createdName=ms6000000252401279, createdTime=Sun Mar 28 08:18:24 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895979, encodeId=c3338959e90e, content=多谢多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/4e67da775f024966bfa59cc158cc8c46/c54a72ef28e94653944444c8f52cc1f2.jpg, createdBy=3eb15410031, createdName=ms6000001661297382, createdTime=Sun Nov 01 00:33:46 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373199, encodeId=b80f3e3199f1, content=多谢分享，让我们了解最新的医药资讯！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c15176498, createdName=146e9b3fm43暂无昵称, createdTime=Wed Sep 25 23:41:48 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-04-02 ms5000000127232937

    jxkmamk

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=953235, encodeId=c4979532355b, content=恭喜贺喜高跟鞋, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:52 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953234, encodeId=00fc95323404, content=jxkmamk, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:13 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951743, encodeId=06b9951e4345, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37e5423044, createdName=ms6000000252401279, createdTime=Sun Mar 28 08:18:24 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895979, encodeId=c3338959e90e, content=多谢多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/4e67da775f024966bfa59cc158cc8c46/c54a72ef28e94653944444c8f52cc1f2.jpg, createdBy=3eb15410031, createdName=ms6000001661297382, createdTime=Sun Nov 01 00:33:46 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373199, encodeId=b80f3e3199f1, content=多谢分享，让我们了解最新的医药资讯！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c15176498, createdName=146e9b3fm43暂无昵称, createdTime=Wed Sep 25 23:41:48 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2021-03-28 ms6000000252401279

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=953235, encodeId=c4979532355b, content=恭喜贺喜高跟鞋, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:52 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953234, encodeId=00fc95323404, content=jxkmamk, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:13 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951743, encodeId=06b9951e4345, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37e5423044, createdName=ms6000000252401279, createdTime=Sun Mar 28 08:18:24 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895979, encodeId=c3338959e90e, content=多谢多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/4e67da775f024966bfa59cc158cc8c46/c54a72ef28e94653944444c8f52cc1f2.jpg, createdBy=3eb15410031, createdName=ms6000001661297382, createdTime=Sun Nov 01 00:33:46 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373199, encodeId=b80f3e3199f1, content=多谢分享，让我们了解最新的医药资讯！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c15176498, createdName=146e9b3fm43暂无昵称, createdTime=Wed Sep 25 23:41:48 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2020-11-01 ms6000001661297382

    多谢多谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=953235, encodeId=c4979532355b, content=恭喜贺喜高跟鞋, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:52 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953234, encodeId=00fc95323404, content=jxkmamk, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=25745459406, createdName=ms5000000127232937, createdTime=Fri Apr 02 09:14:13 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951743, encodeId=06b9951e4345, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a37e5423044, createdName=ms6000000252401279, createdTime=Sun Mar 28 08:18:24 CST 2021, time=2021-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895979, encodeId=c3338959e90e, content=多谢多谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201031/4e67da775f024966bfa59cc158cc8c46/c54a72ef28e94653944444c8f52cc1f2.jpg, createdBy=3eb15410031, createdName=ms6000001661297382, createdTime=Sun Nov 01 00:33:46 CST 2020, time=2020-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=373199, encodeId=b80f3e3199f1, content=多谢分享，让我们了解最新的医药资讯！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c15176498, createdName=146e9b3fm43暂无昵称, createdTime=Wed Sep 25 23:41:48 CST 2019, time=2019-09-25, status=1, ipAttribution=)]
    2019-09-25 146e9b3fm43暂无昵称

    多谢分享，让我们了解最新的医药资讯！

    0

相关指南

2019 国际共识指南：多粘菌素的最佳应用

欧洲临床微生物与感染性疾病学会(ESCMID,European Society of Clinical Microbiology and Infectious Diseases) · 2019-01-30

Baidu
map
Baidu
map
Baidu
map